Please provide your email address to receive an email when new articles are posted on . Incidence of 30-day rebleeding was 7.1% in the vonoprazan group and 10.4% in the proton pump inhibitor group.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback